Charité-Universitätsmedizin Berlin, Campus Virchow-Clinic, Department of Ophthalmology, Augustenburger Platz 1, 13353 Berlin, Germany.
Exp Eye Res. 2012 Jan;94(1):157-73. doi: 10.1016/j.exer.2011.12.002. Epub 2011 Dec 11.
Differences in transient receptor potential (TRP) and cannabinoid receptor type 1 (CB1) expression levels can serve as prognostic factors for retinoblastoma (RB) tumor progression. We hypothesized in RB tissue that such differences are also indicators of whether or not they are sensitive to etoposide. Accordingly, we compared in malignant etoposide-sensitive and etoposide-resistant WERI-Rb1 cells TRPV1, TRPM8 and TRPA1 subtype and CB1 gene expression pattern levels and accompanying functional activity using quantitative real-time RT-PCR, immunohistochemistry, immunofluorescence microscopy, calcium imaging as well as patch-clamp technology. Gene expression patterns were evaluated in enucleated human RB tissues (n = 4). Both etoposide-resistant and etoposide-sensitive WERI-Rb1 cells expressed all of the aforementioned channels based on responses to known activators and thermal challenges. However, TRPA1 was absent in the etoposide-resistant counterpart. Even though both types of RB cells express TRPV1 as well as TRPM8 and CB1, the capsaicin (50 μM) (CAP)-induced Ca(2+) rise caused by TRPV1 activation was prompt and transient only in etoposide-resistant RB cells (n = 8). In this cell type, the inability of CB1 activation (10 μM WIN) to suppress Ca(2+) responses to CAP (50 μM; n = 4) may be attributable to the absence of TRPA1 gene expression. Therefore, using genetic approaches to upregulate TRPA1 expression could provide a means to induce etoposide sensitivity and suppress RB cell tumorigenesis.
瞬时受体电位 (TRP) 和大麻素受体 1 型 (CB1) 表达水平的差异可作为视网膜母细胞瘤 (RB) 肿瘤进展的预后因素。我们假设在 RB 组织中,这些差异也是它们对依托泊苷是否敏感的指标。因此,我们比较了恶性依托泊苷敏感和依托泊苷耐药的 WERI-Rb1 细胞中 TRPV1、TRPM8 和 TRPA1 亚型以及 CB1 基因表达模式水平,并使用定量实时 RT-PCR、免疫组织化学、免疫荧光显微镜、钙成像以及膜片钳技术评估了伴随的功能活性。在眼内容剜除的人 RB 组织中评估了基因表达模式 (n=4)。基于对已知激动剂和热挑战的反应,两种依托泊苷耐药和依托泊苷敏感的 WERI-Rb1 细胞均表达了上述所有通道。然而,TRPA1 在耐药型中不存在。尽管两种类型的 RB 细胞均表达 TRPV1 以及 TRPM8 和 CB1,但依托泊苷耐药 RB 细胞 (n=8) 中 TRPV1 激活引起的辣椒素 (50 μM) (CAP) 诱导的 Ca2+ 升高是迅速而短暂的。在这种细胞类型中,CB1 激活 (10 μM WIN) 不能抑制 CAP (50 μM;n=4) 引起的 Ca2+ 反应可能归因于 TRPA1 基因表达缺失。因此,使用遗传方法上调 TRPA1 表达可能是诱导依托泊苷敏感性和抑制 RB 细胞肿瘤发生的一种手段。